Until peer-reviewed studies validate its effectiveness and safety , patients must approach the treatment with cautious optimism
By the end of the experimental period venous blood samples were collected from the orbital sinus of control and food color treated rats tow fia glass one was containing non agulated material (heparin) for determination hematology and one was used to separation of serum
Caffeine becomes a problem when it contributes to existing imbalances, meaning its not usually the cause but rather an aggravator
Other therapies were linked to increased adverse events such as stroke [11], hyperkalemia [13,15], hypotension [13], acute kidney injury (AKI) [15], and major adverse cardiovascular events (MACE) [14]
In this guide, Ill explain GLP-1 medications in clear, practical terms: how they work, why they are prescribed, what benefits and risks matter most, and how the different options compare
You may be a good candidate for GLP-1 treatment if you: Have been diagnosed with type 2 diabetes Have obesity, or a body mass index (BMI) of 30 or higher Have overweight (a BMI of 25 to 29.9) plus at least one weight-related condition, such as heart disease or type 2 diabetes Ultimately, the decision to start treatment for weight loss is up to you and your healthcare provider